These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9661191)

  • 1. Artificial blood: ancient dream, modern enigma.
    Winslow RM
    Nat Biotechnol; 1998 Jul; 16(7):621-2. PubMed ID: 9661191
    [No Abstract]   [Full Text] [Related]  

  • 2. Temperature stability of Poly-[hemoglobin-superoxide dismutase-catalase-carbonic anhydrase] in the form of a solution or in the lyophilized form during storage at -80 °C, 4 °C, 25 °C and 37 °C or pasteurization at 70 °C.
    Bian YZ; Guo C; Chang TM
    Artif Cells Nanomed Biotechnol; 2016; 44(1):41-7. PubMed ID: 26613265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyhemoglobin-superoxide dismutase-catalase as a blood substitute with antioxidant properties.
    D'Agnillo F; Chang TM
    Nat Biotechnol; 1998 Jul; 16(7):667-71. PubMed ID: 9661202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanobiotechnological modification of hemoglobin and enzymes from this laboratory.
    Chang TM
    Biochim Biophys Acta; 2008 Oct; 1784(10):1435-40. PubMed ID: 18565337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of a hemoglobin polymer containing antioxidant enzymes using complementary chemistry of maleimides and sulfhydryls.
    Tarasov E; Blaszak MM; LaMarre JM; Olsen KW
    Artif Cells Blood Substit Immobil Biotechnol; 2007; 35(1):31-43. PubMed ID: 17364469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two future generations of blood substitutes based on polyhemoglobin-SOD-catalase and nanoencapsulation.
    Chang TM; D'Agnillo F; Yu WP; Razack S
    Adv Drug Deliv Rev; 2000 Feb; 40(3):213-8. PubMed ID: 10837791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modified hemoglobin-based blood substitutes: crosslinked, recombinant and encapsulated hemoglobin.
    Chang TM
    Vox Sang; 1998; 74 Suppl 2():233-41. PubMed ID: 9704450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long term safety and immunological effects of a nanobiotherapeutic, bovine poly-[hemoglobin-catalase-superoxide dismutase-carbonic anhydrase], after four weekly 5% blood volume top-loading followed by a challenge of 30% exchange transfusion.
    Guo C; Chang TMS
    Artif Cells Nanomed Biotechnol; 2018 Nov; 46(7):1349-1363. PubMed ID: 29873524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Future perspectives in blood transfusion.
    Waschke KF; Quintel M; Kerger H; Lenz C
    Acta Anaesthesiol Scand Suppl; 1996; 109():143-7. PubMed ID: 8901987
    [No Abstract]   [Full Text] [Related]  

  • 10. Novel Nanodimension artificial red blood cells that act as O2 and CO2 carrier with enhanced antioxidant activity: PLA-PEG nanoencapsulated PolySFHb-superoxide dismutase-catalase-carbonic anhydrase.
    Gao W; Bian Y; Chang TM
    Artif Cells Nanomed Biotechnol; 2013 Aug; 41(4):232-9. PubMed ID: 23336597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enzymatic protection from autoxidation for crosslinked hemoglobins.
    Yang T; Olsen KW
    Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(3):709-17. PubMed ID: 7994392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microvascular perspective of oxygen-carrying and -noncarrying blood substitutes.
    Intaglietta M; Cabrales P; Tsai AG
    Annu Rev Biomed Eng; 2006; 8():289-321. PubMed ID: 16834558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design of recombinant hemoglobins for use in transfusion fluids.
    Fronticelli C; Koehler RC
    Crit Care Clin; 2009 Apr; 25(2):357-71, Table of Contents. PubMed ID: 19341913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Not blood simple.
    Stokstad E
    Science; 2002 Feb; 295(5557):1003. PubMed ID: 11834812
    [No Abstract]   [Full Text] [Related]  

  • 15. From artificial red blood cells, oxygen carriers, and oxygen therapeutics to artificial cells, nanomedicine, and beyond.
    Chang TM
    Artif Cells Blood Substit Immobil Biotechnol; 2012 Jun; 40(3):197-9. PubMed ID: 22409281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyhemoglobin-superoxide dismutase-catalase-carbonic anhydrase: a novel biotechnology-based blood substitute that transports both oxygen and carbon dioxide and also acts as an antioxidant.
    Bian Y; Rong Z; Chang TM
    Artif Cells Blood Substit Immobil Biotechnol; 2011 Jun; 39(3):127-36. PubMed ID: 21574914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Future generations of red blood cell substitutes.
    Chang TM
    J Intern Med; 2003 May; 253(5):527-35. PubMed ID: 12702030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemoglobin-based oxygen carriers: first, second or third generation? Human or bovine? Where are we now?
    Napolitano LM
    Crit Care Clin; 2009 Apr; 25(2):279-301, Table of Contents. PubMed ID: 19341909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Thermal denaturation of oligomeric proteins: structural and functional modifications, the sequence of steps].
    Artiukhov VG; Basharina OV; Vashanov GA; Nakvasina MA; Putintseva OV
    Biofizika; 2004; 49(4):617-30. PubMed ID: 15458244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemoglobin substitutes.
    Klein HG
    Clin Adv Hematol Oncol; 2008 Aug; 6(8):562-4. PubMed ID: 18820597
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.